Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02375841 · ClinicalTrials.gov registry record
Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers
A clinical trial of Glioblastoma and Brain Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 309
- Enrollment target
- 8
- Study locations
NCT02375841: Active study of Glioblastoma and Brain Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02375841 is a study of Glioblastoma and Brain Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 309 participants, above the 107-participant average among 199 other Glioblastoma trials with a reported enrollment target (189% higher). The trial reports 8 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02375841, a study of Glioblastoma and Brain Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 309 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to learn more about the way physicians communicate with brain tumor patients. This study will look at how oncologists provide information about brain tumors, brain scan results, and treatment options. This study will look at how oncologists provide information about brain tumors, brain scan results, and treatment options. Ultimately, the investigators hope to use these findings to improve communication between patients, caregivers and their doctors.
Primary Outcome
The curability of the patient's cancer (curability) The patient's prognosis (prognosis)The patient's goals of care should his/her condition worsen and he/she becomes critically ill (EOL)
Conditions Studied
Interventions
- BEHAVIORAL psychometric tests, questionnaires and neurocognitive assessments
Study Locations (8)
New Jersey
- Memorial Sloan Kettering Basking Ridge - Basking Ridge
- Memorial Sloan Kettering Monmouth - Middletown
- Memorial Sloan Kettering Bergen - Montvale
New York
- Memorial Sloan Kettering Commack - Commack
- Memorial Sloan Kettering Westchester - Harrison
- Memorial Sloan Kettering Cancer Center - New York
Michigan
- Henry Ford Hospital - Detroit
Vermont
- University of Vermont Medical Center - Burlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 309 participants |
| Start Date | 2015-02 |
| Est. Completion | 2027-02 |
What the registry record for NCT02375841 still lists
NCT02375841 is an observational study that tracks outcomes without assigning an intervention. The registered 309 participants enrollment target is mid-sized for trials with a published cap, above the 107-participant average among 199 other Glioblastoma trials with a reported enrollment target (189% higher).
The record links to 2 conditions, with Glioblastoma appearing as the primary indexed condition, and to 1 intervention - of which psychometric tests, questionnaires and neurocognitive assessments is the first listed.
NCT02375841 lists 8 locations in 4 states (New Jersey, New York, Michigan).
Frequently Asked Questions
What is clinical trial NCT02375841 about?
NCT02375841 is a clinical study titled "Coping With Glioblastoma: A Study of Communication Between Physicians, Patients, and Caregivers". The purpose of this study is to learn more about the way physicians communicate with brain tumor patients. This study will look at how oncologists provide information about brain tumors, brain scan results, and treatment options. This study will look at how oncologists provide information about brai...
What is the current status of trial NCT02375841?
This trial is currently active not recruiting. The enrollment target is 309 participants. The study started on 2015-02. Estimated completion is 2027-02.
What conditions does trial NCT02375841 study?
This clinical trial studies the following conditions: Glioblastoma, Brain Cancer.
What interventions are being tested in trial NCT02375841?
The interventions under investigation include: psychometric tests, questionnaires and neurocognitive assessments (BEHAVIORAL).
Who is sponsoring clinical trial NCT02375841?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02375841 being conducted?
This trial has 8 study locations across Michigan, New Jersey, New York, Vermont. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glioblastoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02375841's enrollment target sits among peer trials
309 19th of 199 higher than 181 of 199 other Glioblastoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Glioblastoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
NovoTTF Treatment Signatures in Glioblastoma Patients At Autopsy
RECRUITING
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
RECRUITING · Phase 2
-
Venous Thromboembolism Prevention in Outpatients With Glioma
RECRUITING · Phase 2
-
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
RECRUITING · Phase 1
-
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03011684 · 309 participants · Phase 3
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
- NCT06915233 · 309 participants · Phase 3
A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
- NCT03039439 · 310 participants
Molecular and Immunohistochemical Profiling of Tumors in Patients With Parathyroid Tumors
- NCT04178018 · 310 participants · NA
Transvaginal Ultrasound and Photoacoustic Imaging of Ovary
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia